ClinicalTrials.Veeva

Menu

Air Optix® Night and Day® Aqua Therapeutic Wear

Alcon logo

Alcon

Status

Completed

Conditions

Corneal Edema
Corneal Erosion
Bullous Keratopathy
Entropion
Corneal Dystrophy

Treatments

Device: Lotrafilcon A contact lenses
Device: Balafilcon A contact lenses

Study type

Observational

Funder types

Industry

Identifiers

NCT05956535
CLD265-N001

Details and patient eligibility

About

The purpose of this study is to support the safety and performance assessment of Air Optix Night and Day Aqua (AONDA) soft contact lenses for therapeutic use in accordance with updated EU Medical Device Regulation (MDR) requirements.

Full description

In this retrospective, real world evidence study, the subjects wore Air Optix Night and Day Aqua (AONDA) soft contact lenses or PureVision 2 (PV2) soft contact lenses as a therapeutic lens for the treatment of a corneal condition with pain in one or both eyes as part of their eye care professional's treatment and management plan.

Enrollment

168 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of a corneal condition with pain for which AONDA or PV2 contact lenses were placed on one or both eye(s) as a therapeutic contact lens at Baseline.
  • Baseline and Follow-up (up to 1 year from Baseline) charts available.
  • Other protocol-defined inclusion criteria may apply.

Exclusion criteria

  • Had a condition (pathological, behavioral, and/or situational) that contraindicated therapeutic CL wear or confounds study results during the data collection period.
  • Used systemic or ocular medication that would confound study results during the data collection period.
  • Other protocol-defined exclusion criteria may apply.

Trial design

168 participants in 2 patient groups

AONDA contact lenses
Description:
Lotrafilcon A contact lenses worn therapeutically as a bandage lens in a continuous wear (CW) modality (lenses worn continuously including overnight) as instructed by the eye care professional.
Treatment:
Device: Lotrafilcon A contact lenses
PV2 contact lenses
Description:
Balafilcon A contact lenses worn therapeutically as a bandage lens in a continuous wear (CW) modality (lenses worn continuously including overnight) as instructed by the eye care professional.
Treatment:
Device: Balafilcon A contact lenses

Trial contacts and locations

3

Loading...

Central trial contact

Alcon Call Center

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems